Medicare's Historic Prescription Drug Price Negotiations

Lawrence O Gostin; James G Hodge Jr; Andrew J Twinamatsiko

doi:10.1001/jama.2023.19506

Medicare's Historic Prescription Drug Price Negotiations

JAMA. 2023 Nov 7;330(17):1621-1622. doi: 10.1001/jama.2023.19506.

Authors

Lawrence O Gostin¹, James G Hodge Jr², Andrew J Twinamatsiko¹

Affiliations

¹ O'Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, DC.
² Center for Public Health Law and Policy, ASU Sandra Day O'Connor College of Law, Phoenix, Arizona.

PMID: 37728954
DOI: 10.1001/jama.2023.19506

No abstract available

Plain language summary

This Viewpoint evaluates the legal claims and policy implications of historic drug price negotiations possible with the Inflation Reduction Act of 2022.

MeSH terms

Drug Costs* / legislation & jurisprudence
Medicare* / economics
Medicare* / legislation & jurisprudence
Negotiating
Prescription Drugs* / economics
Prescriptions
United States

Substances

Prescription Drugs